Drug Type Small molecule drug |
Synonyms MAX 40070, MAX-3 |
Target |
Mechanism JAK inhibitors(Janus kinase inhibitors), TYK2 inhibitors(Tyrosine-protein kinase 2 inhibitors) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alopecia | Phase 1 | NZ | 31 Jan 2022 | |
Dermatitis, Atopic | Phase 1 | NZ | 31 Jan 2022 | |
Psoriasis | Phase 1 | NZ | 31 Jan 2022 |